Last updated: March 9, 2023
Sponsor: Jose Luis Ibañez Criado
Overall Status: Active - Recruiting
Phase
N/A
Condition
Dysrhythmia
Arrhythmia
Atrial Flutter
Treatment
N/AClinical Study ID
NCT05777850
FASD-HP trial
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with cavotricuspid isthmus dependent flutter referred to ablation
- Patients clinically and hemodynamically stable.
- Patients who give informed consent.
Exclusion
Exclusion Criteria:
- Refusal to participate in the register or inability to understand the informedconsent.
- Age under 18.
- Patients who have already undergone previous flutter ablation procedures.
Study Design
Total Participants: 120
Study Start date:
October 25, 2022
Estimated Completion Date:
April 30, 2025
Connect with a study center
Hospital General Doctor Balmis Alicante
Alicante, A 03010
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.